US-based Warburg Pincus in talks to buy Maneesh Pharma unit in Rs 1,800 crore deal

US private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is valued between ₹1,600 to ₹1,800 crore. This move is part of Warburg's strategy to build a larger pharmaceutical platform in India. A formal announcement is anticipated in the coming months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J6oL8TN
via IFTTT